Natural Capsules Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Natural Capsules Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 11% in 3 years, but profit fell: ₹235 less profit per ₹100 of extra sales. Lower than almost all Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 98% of Healthcare companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 98% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.2×Over the last 3 years its own operating cash paid for 23% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 88% of Healthcare companies in India.
Cash Locked Ratio
₹19For every ₹100 of sales, ₹19 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹15 tied up three years earlier.
Less money tied up than 63% of Healthcare companies in India.
Growth quality
Steadiness Ratio
2/3 · 0/3Sales grew in 2 of the last 3 years; profit grew in 0 of 3.
Less steady than 94% of Healthcare companies in India.
Growth Efficiency Ratio
−₹235Sales grew 11% in 3 years, but profit fell: ₹235 less profit per ₹100 of extra sales.
Lower than almost all Healthcare companies in India.
Asset Productivity Ratio
+11% / +47%In 3 years sales changed by +11% while total assets changed by +47%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.2×Debt due within a year is covered 0.2 times by its yearly operating cash.
Lower than 84% of Healthcare companies in India.
Cash Cushion Ratio
−71%Debt, after subtracting cash, equals 71% of its market value (net debt).
Lower than 97% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 98% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 98% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Natural Capsules Limited made a loss over the last year. Natural Capsules Limited owes ₹0.45 for every ₹1 it owns. Natural Capsules Limited made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
LossNatural Capsules Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.71The share price is 0.71 times Natural Capsules Limited's book value per share, lower than 98% of Healthcare companies in India.
Market cap
₹157 CrThe total market value of all of Natural Capsules Limited's shares at today's price (share price × number of shares), smaller than 93% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹222 CrWhat Natural Capsules Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹212.88Net worth divided by the number of shares. The share price of ₹150.33 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-11.2%Natural Capsules Limited lost 11.2% of its shareholders' money over the last year, lower than 98% of Healthcare companies in India.
Owes vs Owns
0.45×Natural Capsules Limited owes ₹0.45 for every ₹1 it owns (low), higher than 71% of Healthcare companies in India.
Dividend yield
NoneNatural Capsules Limited does not currently pay a dividend.
Revenue growth
+12%Revenue rose 12% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Profit growth
LossNatural Capsules Limited made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-13.5%Natural Capsules Limited lost ₹13 for every ₹100 of revenue.
Interest cover
Not coveredNatural Capsules Limited's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net debtNatural Capsules Limited had ₹111 Cr more debt than cash (net debt) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Natural Capsules Limited: ₹157 Cr ÷ ₹222 Cr (31 Mar 2026) = 0.7.
What is Natural Capsules Limited's return on equity?
Natural Capsules Limited lost 11.2% of its shareholders' money over the last year, lower than 98% of Healthcare companies in India.
How much does Natural Capsules Limited owe compared with what it owns?
Natural Capsules Limited owes ₹0.45 for every ₹1 it owns (low), higher than 71% of Healthcare companies in India.
Does Natural Capsules Limited pay a dividend?
No. Natural Capsules Limited does not currently pay a dividend.
Is Natural Capsules Limited's revenue growing?
Revenue rose 12% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.